Annual Short Term Debt
$489.00 K
+$165.00 K+50.93%
December 1, 2024
Summary
- As of February 26, 2025, VKTX annual short term debt is $489.00 thousand, with the most recent change of +$165.00 thousand (+50.93%) on December 1, 2024.
- During the last 3 years, VKTX annual short term debt has risen by +$460.00 thousand (+1586.21%).
- VKTX annual short term debt is now -85.83% below its all-time high of $3.45 million, reached on December 31, 2017.
Performance
VKTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$489.00 K
+$9000.00+1.88%
December 1, 2024
Summary
- As of February 26, 2025, VKTX quarterly short term debt is $489.00 thousand, with the most recent change of +$9000.00 (+1.88%) on December 1, 2024.
- Over the past year, VKTX quarterly short term debt has stayed the same.
- VKTX quarterly short term debt is now -86.86% below its all-time high of $3.72 million, reached on March 31, 2018.
Performance
VKTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VKTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.9% | 0.0% |
| 3 y3 years | +1586.2% | +1586.2% |
| 5 y5 years | +61.9% | +61.9% |
VKTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1586.2% | at high | +1586.2% |
| 5 y | 5-year | at high | +1586.2% | at high | +1586.2% |
| alltime | all time | -85.8% | -100.0% | -86.9% | -100.0% |
Viking Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $489.00 K(+50.9%) | $489.00 K(+1.9%) |
| Sep 2024 | - | $480.00 K(+43.7%) |
| Jun 2024 | - | $334.00 K(+1.5%) |
| Mar 2024 | - | $329.00 K(+1.5%) |
| Dec 2023 | $324.00 K(+6.6%) | $324.00 K(+1.6%) |
| Sep 2023 | - | $319.00 K(+1.6%) |
| Jun 2023 | - | $314.00 K(+1.6%) |
| Mar 2023 | - | $309.00 K(+1.6%) |
| Dec 2022 | $304.00 K(+948.3%) | $304.00 K(+1.7%) |
| Sep 2022 | - | $299.00 K(+25.6%) |
| Jun 2022 | - | $238.00 K(+58.7%) |
| Mar 2022 | - | $150.00 K(+417.2%) |
| Dec 2021 | $29.00 K(-91.2%) | $29.00 K(-74.8%) |
| Sep 2021 | - | $115.00 K(-41.9%) |
| Jun 2021 | - | $198.00 K(-29.0%) |
| Mar 2021 | - | $279.00 K(-15.5%) |
| Dec 2020 | $330.00 K | $330.00 K(+2.2%) |
| Sep 2020 | - | $323.00 K(+2.2%) |
| Jun 2020 | - | $316.00 K(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $309.00 K(+2.3%) |
| Dec 2019 | $302.00 K(>+9900.0%) | $302.00 K(+2.4%) |
| Sep 2019 | - | $295.00 K(+2.4%) |
| Jun 2019 | - | $288.00 K(+2.5%) |
| Mar 2019 | - | $281.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2018 | - | $3.72 M(+7.8%) |
| Dec 2017 | $3.45 M(+5.5%) | $3.45 M(+8.5%) |
| Sep 2017 | - | $3.18 M(+4.3%) |
| Jun 2017 | - | $3.05 M(-6.7%) |
| Dec 2016 | $3.27 M(+974.5%) | $3.27 M(+15.7%) |
| Sep 2016 | - | $2.83 M(+18.6%) |
| Jun 2016 | - | $2.38 M(+24.7%) |
| Sep 2015 | - | $1.91 M(+14.4%) |
| Jun 2015 | - | $1.67 M(+438.2%) |
| Mar 2015 | - | $310.40 K(+2.0%) |
| Dec 2014 | $304.30 K(+548.8%) | $304.30 K(+4.4%) |
| Jun 2014 | - | $291.50 K(+508.6%) |
| Mar 2014 | - | $47.90 K |
| Dec 2013 | $46.90 K | - |
FAQ
- What is Viking Therapeutics annual short term debt?
- What is the all time high annual short term debt for Viking Therapeutics?
- What is Viking Therapeutics annual short term debt year-on-year change?
- What is Viking Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Viking Therapeutics?
- What is Viking Therapeutics quarterly short term debt year-on-year change?
What is Viking Therapeutics annual short term debt?
The current annual short term debt of VKTX is $489.00 K
What is the all time high annual short term debt for Viking Therapeutics?
Viking Therapeutics all-time high annual short term debt is $3.45 M
What is Viking Therapeutics annual short term debt year-on-year change?
Over the past year, VKTX annual short term debt has changed by +$165.00 K (+50.93%)
What is Viking Therapeutics quarterly short term debt?
The current quarterly short term debt of VKTX is $489.00 K
What is the all time high quarterly short term debt for Viking Therapeutics?
Viking Therapeutics all-time high quarterly short term debt is $3.72 M
What is Viking Therapeutics quarterly short term debt year-on-year change?
Over the past year, VKTX quarterly short term debt has changed by $0.00 (0.00%)